Koliber Biosciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $225K

  • Investors
  • 2

Koliber Biosciences General Information

Description

Developer of artificial intelligence platforms intended for applications in peptide discovery, statistical analysis, and microbiome engineering. The company's platform integrates AI-driven encoding methods, tunable algorithms, and model architectures suitable for small and large datasets, combined with training programs in statistical approaches and complemented by genome engineering technologies for microbiome and probiotic strains, enabling pharmaceutical, biotechnology, and research organizations to improve discovery workflows, optimize experimental design, accelerate therapeutic development, and achieve more reproducible and scalable outcomes across multiple scientific domains.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 12265 World Trade Drive
  • Suite G
  • San Diego, CA 92128
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Other Healthcare Technology Systems
Corporate Office
  • 12265 World Trade Drive
  • Suite G
  • San Diego, CA 92128
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Koliber Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jun-2020 $225K Completed Generating Revenue
2. Grant 01-Apr-2018 Completed Generating Revenue
1. Accelerator/Incubator 01-May-2015 Completed Generating Revenue
To view Koliber Biosciences’s complete valuation and funding history, request access »

Koliber Biosciences Patents

Koliber Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260062445-A1 Peptides with cytokine-releasing activity and methods for characterizing cytokine-releasing profiles of peptides Pending 09-Sep-2022
WO-2024054928-A1 Peptides with cytokine-releasing activity and methods for characterizing cytokine-releasing profiles of peptides Inactive 09-Sep-2022

Koliber Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Koliber Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
Bio, Tech and Beyond Accelerator/Incubator Minority
To view Koliber Biosciences’s complete investors history, request access »

Koliber Biosciences FAQs

  • When was Koliber Biosciences founded?

    Koliber Biosciences was founded in 2014.

  • Where is Koliber Biosciences headquartered?

    Koliber Biosciences is headquartered in San Diego, CA.

  • What is the size of Koliber Biosciences?

    Koliber Biosciences has 7 total employees.

  • What industry is Koliber Biosciences in?

    Koliber Biosciences’s primary industry is Biotechnology.

  • Is Koliber Biosciences a private or public company?

    Koliber Biosciences is a Private company.

  • What is Koliber Biosciences’s current revenue?

    The current revenue for Koliber Biosciences is .

  • How much funding has Koliber Biosciences raised over time?

    Koliber Biosciences has raised $225K.

  • Who are Koliber Biosciences’s investors?

    US National Science Foundation and Bio, Tech and Beyond have invested in Koliber Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process